Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates.
WuQiang FanMelissa MachadoBenjamin Z LederLisa BeyerEsteban Franco GarciaHenry M KronenbergSmriti CevallosJosue EspinozaJoel S FinkelsteinMarcy B BolsterPublished in: The Journal of clinical endocrinology and metabolism (2022)
Integration of a FLS and Orthopedics services along with inpatient ZA administration improved the osteoporosis pharmacotherapy rate among patients with fragility fracture(s) who often had obstacles for outpatient follow-up.